The global pharmaceutical unit-dose packaging market size accounted for US$ 35.40 billion in 2023 and is projected to reach around USD 141.36 billion by 2033, growing at a CAGR of 14.85% from 2024 to 2033.
Key Points
- North America held the largest market share of 34% in 2023.
- Asia Pacific is observed to witness the fastest rate of expansion during the forecast period.
- By material, the plastic segment dominated the market with the highest revenue share of 48% in 2023.
- By material, the glass material segment holds a significant share of the market.
- By product type, the vials segment has captured the largest market share of 30% in 2023.
- By product type, the blisters segment is observed to witness the fastest rate of expansion during the forecast period.
- By end-use, the oral segment dominated the market in 2023.
Report Summary
The global pharmaceutical unit-dose packaging market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.
The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the pharmaceutical unit-dose packaging market across the globe.
A comprehensive estimate on the pharmaceutical unit-dose packaging market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of pharmaceutical unit-dose packaging during the forecast period. Price point comparison by region with global average price is also considered in the study.
Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/3896
Pharmaceutical Unit-dose Packaging Market Scope
| Report Coverage | Details |
| Growth Rate from 2024 to 2033 | CAGR of 14.85% |
| Global Market Size in 2023 | USD 35.40 Billion |
| Global Market Size by 2033 | USD 141.36 Billion |
| U.S. Market Size in 2023 | USD 8.43 Billion |
| U.S. Market Size by 2033 | USD 33.64 Billion |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | By Material, By Product, and By End-use |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Key Highlights:
Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized pharmaceutical unit-dose packaging market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.
Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.
Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.
Also Read: IT Devices Market Size to Cross USD 4,436.53 Bn by 2033
Market Players
The report includes the profiles of key pharmaceutical unit-dose packaging market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.
Recent Developments
- In December 2023, Sun Pharmaceutical Industries Ltd launched the ‘es-omeprazole’ the chiral version of the anti-ulcerant drug omeprazole. This version of the medicine is lesser in side effects and is considered more efficient than the molecule itself.
- In 2023, Gerresheimer Gx Solutions is designing packaging solutions for complex injectable drugs. Gerresheimer Gx Solutions working on the primary packaging solution for sensitive injectable drugs. The organization integrated expertise in the specialized team known as Gx Solutions.
- In January 2024, a clean technology company “Loop Industries”, launched the latest pharmaceutical packaging bottles in partnership with Bormioli Pharma. The bottle is made up of 100% recycled virgin quality Loop polyethylene terephthalate (PET) resin.
Pharmaceutical Unit-dose Packaging Market Companies
- Pfizer Inc
- Bristol-Myers Squibb Company
- Merck & Co. Inc.
- AbbVie Inc.
- Gerresheimer AG
- Comar LLC
- Amcor Plc.
- Johnson & Johnson
- UDG Healthcare Plc
- Berry Global, Inc.
Segments Covered in the Report
By Material
- Plastics
- Glass
- Paper and Paperboard
- Metal
By Product
- Vials
- Syringe and cartridge
- Ampoules
- Blisters
By End-use
- Ophthalmic
- Injectable
- Biologics
- Wound Care
- Respiratory Therapy
- Orals
Regional Segmentation
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
- Latin America (Brazil and Rest of Latin America)
- Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
Research Methodology
Secondary Research
It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.
The secondary research sources referred in the process are as follows:
- Governmental bodies, and organizations creating economic policies
- National and international social welfare institutions
- Company websites, financial reports and SEC filings, broker and investor reports
- Related patent and regulatory databases
- Statistical databases and market reports
- Corporate Presentations, news, press release, and specification sheet of Manufacturers
Primary Research
Primary research includes face-to-face interviews, online surveys, and telephonic interviews.
- Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
- In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Pharmaceutical Unit-dose Packaging Market
5.1. COVID-19 Landscape: Pharmaceutical Unit-dose Packaging Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Pharmaceutical Unit-dose Packaging Market, By Material
8.1. Pharmaceutical Unit-dose Packaging Market Revenue and Volume, by Material, 2024-2033
8.1.1 Plastics
8.1.1.1. Market Revenue and Volume Forecast (2021-2033)
8.1.2. Glass
8.1.2.1. Market Revenue and Volume Forecast (2021-2033)
8.1.3. Paper and Paperboard
8.1.3.1. Market Revenue and Volume Forecast (2021-2033)
8.1.4. Metal
8.1.4.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 9. Global Pharmaceutical Unit-dose Packaging Market, By Product
9.1. Pharmaceutical Unit-dose Packaging Market Revenue and Volume, by Product, 2024-2033
9.1.1. Vials
9.1.1.1. Market Revenue and Volume Forecast (2021-2033)
9.1.2. Syringe and Cartridge
9.1.2.1. Market Revenue and Volume Forecast (2021-2033)
9.1.3. Ampoules
9.1.3.1. Market Revenue and Volume Forecast (2021-2033)
9.1.4. Blisters
9.1.4.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 10. Global Pharmaceutical Unit-dose Packaging Market, By End-use
10.1. Pharmaceutical Unit-dose Packaging Market Revenue and Volume, by End-use, 2024-2033
10.1.1. Ophthalmic
10.1.1.1. Market Revenue and Volume Forecast (2021-2033)
10.1.2. Injectable
10.1.2.1. Market Revenue and Volume Forecast (2021-2033)
10.1.3. Biologics
10.1.3.1. Market Revenue and Volume Forecast (2021-2033)
10.1.4. Wound Care
10.1.4.1. Market Revenue and Volume Forecast (2021-2033)
10.1.5. Respiratory Therapy
10.1.5.1. Market Revenue and Volume Forecast (2021-2033)
10.1.6. Others
10.1.6.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 11. Global Pharmaceutical Unit-dose Packaging Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Material (2021-2033)
11.1.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.1.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Material (2021-2033)
11.1.4.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.1.4.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Material (2021-2033)
11.1.5.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.1.5.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Material (2021-2033)
11.2.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.2.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Material (2021-2033)
11.2.4.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.2.4.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Material (2021-2033)
11.2.5.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.2.5.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Material (2021-2033)
11.2.6.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.2.6.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Material (2021-2033)
11.2.7.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.2.7.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Material (2021-2033)
11.3.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.3.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Material (2021-2033)
11.3.4.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.3.4.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Material (2021-2033)
11.3.5.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.3.5.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Material (2021-2033)
11.3.6.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.3.6.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Material (2021-2033)
11.3.7.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.3.7.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Material (2021-2033)
11.4.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.4.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Material (2021-2033)
11.4.4.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.4.4.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Material (2021-2033)
11.4.5.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.4.5.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Material (2021-2033)
11.4.6.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.4.6.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Material (2021-2033)
11.4.7.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.4.7.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Material (2021-2033)
11.5.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.5.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Material (2021-2033)
11.5.4.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.5.4.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Material (2021-2033)
11.5.5.2. Market Revenue and Volume Forecast, by Product (2021-2033)
11.5.5.3. Market Revenue and Volume Forecast, by End-use (2021-2033)
Chapter 12. Company Profiles
12.1. Pfizer Inc
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Bristol-Myers Squibb Company
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Merck & Co. Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. AbbVie Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Gerresheimer AG
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Comar LLC
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Amcor Plc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Johnson & Johnson
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. UDG Healthcare Plc
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Berry Global, Inc.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
